![]() |
Volumn 13, Issue 2, 2013, Pages 141-142
|
Will SCNT-ESCs be better than iPSCs for personalized regenerative medicine?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MITOCHONDRIAL DNA;
BLASTOCYST;
CANCER CELL;
CARCINOGENESIS;
CELL DEDIFFERENTIATION;
CELL DIFFERENTIATION;
CELL FUNCTION;
CELL NUCLEUS TRANSPLANTATION;
CELL PROLIFERATION;
CELL TRANSFORMATION;
DISORDERS OF MITOCHONDRIAL FUNCTIONS;
EMBRYONIC STEM CELL;
ENGRAFTMENT;
FIBROBLAST;
GENE AMPLIFICATION;
HETEROPLASMY;
HUMAN;
IMMUNOGENICITY;
IN VIVO STUDY;
LEIGH DISEASE;
LETTER;
MALIGNANT TRANSFORMATION;
MITOCHONDRIAL GENOME;
MOLECULAR INTERACTION;
OOCYTE;
PERSONALIZED MEDICINE;
PHENOTYPE;
PLASTICITY;
PLURIPOTENT STEM CELL;
PRIORITY JOURNAL;
REGENERATIVE MEDICINE;
REPRODUCIBILITY;
SOMATIC CELL;
SOMATIC CELL NUCLEAR TRANSFER;
SPONTANEOUS MUTATION;
STEM CELL TRANSPLANTATION;
|
EID: 84881164868
PISSN: 19345909
EISSN: 18759777
Source Type: Journal
DOI: 10.1016/j.stem.2013.07.013 Document Type: Letter |
Times cited : (4)
|
References (10)
|